You might also like

More about Effect of Metrofim and Vildagliptin in Type II diabetes

• Book details
• Synopsis
• Trending among others

You get 117 loyalty points

Book synopsis

Diabetes mellitus is a group of metabolic disorder characterized by hyperglycaemia and altered metabolism of lipid, protein and carbohydrate. In diabetes there is total or subtotal deficiency of insulin along incetine defice.Insulin and many oral hypoglycemic drugs and are available for the treatment of Type II still target HbA1c is not achived. Vildaglipton selective inhibitor of Dipeptidyl Peptidase-4 (DPP-4), the enzyme responsible for the rapid degradation of circulating Glucagon - like Peptide-1.It improves islet function in patients with type-2 diabetes by increasing both and cell responsiveness to glucose and decrease fasting plasma glucose (FPG) and postprandial glucose.Metformin is the most commonly prescribed first-line hypoglycaemic drug worldwide, but due to the progressive worsening of blood glucose control during the natural history of type-2 diabetes, combination therapy usually becomes necessary.Therefore, it was of interest to ascertain the efficacy and tolerability of Vildagliptin, Metformin alone and in combination of both in type-2 diabetic patients.We got encouraging result with combination.

Book details

• Full title: Effect of Metrofim and Vildagliptin in Type II diabetes
• Subtitle: Vildagliptin a new drug treatment for Type II Diabetes
• Author: Deepak Bhosle, Asmita Hingole, Vandana Bhosle
• Language: English
• Binding: Paperback
• Number of pages: 104
• EAN: 9783659257858
• ID: 06887889
• Publisher: LAP Lambert Academic Publishing
• Weight: 173 g
• Dimensions: 220 × 150 × 6 mm
• Published: 2012

Trending among others

---

---

---